Navigation Links
A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients

e specifically, the mean HbA1c level among treated patients was reduced 0.43%, 0.94% (p<0.05), 1.09% (p<0.05), 1.12% (p<0.05), 1.21% (p<0.05), and 1.14% in months 1, 2, 3, 4, 5, and 6 post-treatment, respectively. In contrast, the mean HbA1c levels of the placebo group ranged from a reduction of 0.1% to an increase of 1.0% over the same period. In addition to the HbA1c reductions, the data demonstrated decreases in fasting blood glucose levels as well as improvements in glucose tolerance over a six month period following treatment with E1-I.N.T.(TM). Trends in increased insulin levels as measured with an oral glucose tolerance test were also observed, particularly in patients where the HbA1c levels decreased over 1% with E1-I.N.T.(TM) therapy. These data are consistent with the increased glucose control observed in diabetes animal models where a short treatment with E1-I.N.T.(TM) resulted in a sustained increase in beta cell mass and function. These clinical improvements, including HbA1c reductions greater than 1% in patients six month post-treatment, highlight the potential that E1-I.N.T.(TM) therapy could provide patients significant clinical benefit in excess of 6 months.

Safety and Tolerability Findings:

There were no serious adverse events noted during the study. As described in Transition's press release of March 5th, 2007, the most common adverse events reported by patients receiving E1-I.N.T.(TM), were nausea, diarrhea, headaches and vomiting which were generally mild to moderate in nature. The majority of these adverse events were reported during the treatment period with the occurrence of adverse events in the post-treatment phase being similar in both the treated and placebo groups.

Next Steps:

In this study, the tolerable dosing levels of E1-I.N.T.(TM) and the efficacy parameters to be employed in future clinical studies were established. Building upon these sustained efficacy findings, the next steps in clinical development w
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
7. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
8. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
9. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
10. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
11. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy

Post Your Comments:
(Date:11/27/2009)..., , CHICAGO, Nov. 27 At ... (RSNA) annual meeting starting Sunday, Royal Phil...a new range of healthcare imaging and informatics ...ies of patients and care providers, by delivering ...re for value, modular price points and easy upgrad...
(Date:11/25/2009)..., , LOVELAND, Colo., Nov. 25 /PRNewswire-..., a leading provider of advanced diagnostic and ...ounced today agreements with Roche Diagnostics Cor...affiliated consumables for the veterinary market. ...rnh/20000622/HESKALOGO ) ,, "Heska and Roche sh...
(Date:11/25/2009)..., , CHICAGO and STAFA, Switzerland, Nov. 25 ...leading manufacturer of innovative hearing solutio...re for Adults Conference, focusing on the special ...ght together leading experts in aging and audiolog...ns who work everyday with older people with hearin...
Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 48555 1Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 48555 2Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 48555 3Doctors Can Chat Online While Job Searching 48553 1Doctors Can Chat Online While Job Searching 48553 2Doctors Can Chat Online While Job Searching 48553 3Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 1Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 2Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 3
...SINESS WIRE)--Jun 25, 2007 - Elixir,Pharmaceutical...al,data highlighting the ability of Glufast(R) (mi...tion therapy with metformin, to,manage glucose sur...d in the Abstract Book for the American Diabetes,A...ago, Illinois.,Glufast is an insulin secretagogue ...
...INESS WIRE)--Jun 25, 2007 - Neurogen,Corporation (...sults from two dose-ranging, Phase 2b clinical tri...s proprietary insomnia agent,NG2-73, an alpha-3 p...ations were studied in each trial to determine the...tenance of sleep,through the night without residua...
Other Medicine Technology:Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 2Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 3Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 4Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 2Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 4Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 6Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 7Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 8
(Date:11/27/2009)...wswire/ -- Considered a highly risky and controver...gan transplantation is now a life-saving mainstrea...men who gathered at the Winspear Opera House in Da...l centers around the world to celebrate the 25th a... (BRTI), one of the pioneers of solid organ transp...
(Date:11/27/2009).... 27 Team Garmin-Slipstream, the e...to ethical sporting and developing the next genera... will become Team Garmin-Transitions with the addi...e team. Transitions Optical is the world,s leading...st advanced photochromic technology in the widest ...
(Date:11/27/2009)...es may reduce future disease burden, researchers s...-- Encouraging city dwellers to walk and bicycle i...ic health benefits than increased used of low-emis...he study compared the projected health effects in ... for London, England, and Delhi, India: business-...
(Date:11/27/2009)...e; announced today that Spectrum Health (Grand Rap...se orthopedic templating solution and its TraumaCa... (PRWEB) November 27, 2009 -- Voyant Health&tr...apids, Michigan) has licensed its TraumaCad Enterp...Cad Extend workflow solution, to allow its orthope...
(Date:11/27/2009)...ive anatomy education apps from Modality and Lippi...s learning opportunities for iPhone and iPod touch...ember 27, 2009 -- Modality, Inc. and Lippincott ...s Kluwer Health, today announced the availability ...re. Clemente’s Anatomy, Rohen’s Photog...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
... profound findings claiming that not only do hea...rth to girl children, they also run// the risk of ...ially if they and their partners smoke. The st...n-smokers. This chance was lessened to one–half if...
...al Practice Guidelines (CPG) has recommended that ...ults. // It also added that a national surveillanc...rement along with height and weight. This re...ent and prevention of overweight and obesity in ad...
...gulatory body to address issues such as food quali...aid here Tuesday. // "We have been concerne...item-specific and dealt with by different agencies...scientific regulatory body," Ramadoss said while i...
...a heat wave with day temperatures in state capital...rh shooting// up to 42 degrees Celsius. Road...orba. In Raipur, people preferred to remain indoor...eratures at 45 degrees Celsius while night tempera...
...lti-national, the Abbott, has agreed to lower the ...ome countries to one thousand// US dollars, on a r...or-General Margaret Chan. Kaletra is indicate...ry of HIV medicines called protease inhibitors (PI...
...ressed. Who wouldn’t be with a daughter like Trace...ffing her way through// a mountain of cigarettes t...ow (née Hunt, formerly Langton and Rachid) is a lo...cratchy voice (caused by real-life chain smoking) ...
Other Medicine News:Health News:Sons Gone Up In Smoke 2Health News:New Guidelines to Address Growing Obesity Epidemic 2Health News:New Guidelines to Address Growing Obesity Epidemic 3Health News:Abbott to Subsidize Price of HIV Drug 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 3
FSH Urine Test - Rapid Test
...s the worlds first miniaturized cardiovascular ult...eatured imaging in a lightweight design. , , ...in cardiovascular care access to complete, real-t... the reach of echocardiography by offering all the...
Myoglobin - Rapid Test
Troponin I - Rapid Test
Medicine Products: